Attovia Therapeutics Inc. Logo

Attovia Therapeutics Inc. (ATTO)

NYSE

Currency in USD
20.62
-0.18 (-0.87%)

Closed

Aug 24, 2026

Day's Range

19.74
20.96

52 wk Range

16.15
24.32

Recommendations - ATTO - Attovia Therapeutics Inc.

Analyst Ratings - ATTO - Attovia Therapeutics Inc.

Analyst ratings

DateFirmActionRating
Aug 15, 2022Barrington ResearchMaintainsOutperform
Jul 05, 2022Goldman SachsMaintainsNeutral
Sep 21, 2021Goldman SachsUpgradeSell → Neutral
Nov 25, 2020Goldman SachsDowngradeNeutral → Sell
Nov 25, 2020Morgan StanleyDowngradeOverweight → Equal-Weight
Nov 25, 2020BairdMaintainsOutperform
Nov 25, 2020Bank of AmericaMaintainsNeutral
Nov 25, 2020Barrington ResearchInitiates coverageOutperform
Nov 25, 2020Credit SuisseDowngradeOutperform → Neutral
Apr 30, 2020Goldman SachsDowngradeNeutral → Sell
Items per row:

Estimates - ATTO - Attovia Therapeutics Inc.

Growth estimates

Next 5 years (per year)-39.3%
Past 5 years (per year)-39.3%

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - ATTO - Attovia Therapeutics Inc.

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2022-11-14--0.170.10+0.27‪-158.82%‬
2022-08-03--0.15-0.83-0.68‪+453.33%‬
2022-05-10--0.54-4.99-4.45‪+824.07%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.